Pakistan (Muhammad Yasir)
The general public will subscribe 6.25 million shares, 25 percent of
the total offer size of BF Biosciences IPO on October 2nd and 3rd at the strike
price of Rs 77. The general public can subscribe the IPO on
2nd and 3rd October from 9.00 am to 5pm during banking hours. However, in the
case of e-IPO, the process continues for 24 hours. The book-building phase of BF Biosciences
concluded last week with an oversubscription of 3.4 times. The IPO received an overwhelming response
from institutional investors and high-net worth individuals as the strike price
clocked in at Rs 77/share, 40 percent higher than the floor price of Rs 55 and
raised Rs 1.93 billion. Shahid Ali, CEO Arif Habib Limited said
that investing in the public offering of BF Biosciences presents a decent
opportunity for retail investors to engage with a fundamentally strong company
at a more attractive valuation compared to the broader pharmaceutical sector. This unique positioning allows investors tocapitalize on potential growth while benefiting from afavorable entry point.
